WCG Wealth Advisors LLC Purchases 3,790 Shares of Sanofi (NASDAQ:SNY)

WCG Wealth Advisors LLC increased its position in Sanofi (NASDAQ:SNY) by 12.4% during the second quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 34,245 shares of the company’s stock after purchasing an additional 3,790 shares during the quarter. WCG Wealth Advisors LLC’s holdings in Sanofi were worth $1,662,000 as of its most recent SEC filing.

Several other hedge funds have also bought and sold shares of the company. POM Investment Strategies LLC bought a new position in Sanofi during the second quarter worth $25,000. Frazier Financial Advisors LLC bought a new stake in shares of Sanofi during the 4th quarter worth about $28,000. Register Financial Advisors LLC acquired a new position in Sanofi in the 1st quarter valued at about $29,000. Larson Financial Group LLC raised its holdings in Sanofi by 480.8% in the 1st quarter. Larson Financial Group LLC now owns 604 shares of the company’s stock valued at $29,000 after acquiring an additional 500 shares during the period. Finally, Johnson Financial Group Inc. acquired a new stake in Sanofi during the fourth quarter worth approximately $31,000. 10.04% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

SNY has been the topic of several research reports. Citigroup raised Sanofi to a “strong-buy” rating in a research report on Tuesday. StockNews.com downgraded Sanofi from a “strong-buy” rating to a “buy” rating in a report on Wednesday, September 11th. Finally, Argus boosted their target price on shares of Sanofi from $55.00 to $60.00 and gave the company a “buy” rating in a research report on Friday, July 26th. Three investment analysts have rated the stock with a hold rating, two have assigned a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $57.50.

Sanofi Trading Up 1.4 %

Shares of NASDAQ:SNY opened at $58.26 on Friday. The business’s 50 day simple moving average is $54.08 and its 200 day simple moving average is $50.35. Sanofi has a 1 year low of $42.63 and a 1 year high of $58.97. The company has a debt-to-equity ratio of 0.17, a current ratio of 1.00 and a quick ratio of 0.65. The company has a market capitalization of $147.56 billion, a P/E ratio of 29.28, a P/E/G ratio of 1.62 and a beta of 0.60.

Sanofi (NASDAQ:SNY) last posted its quarterly earnings data on Thursday, July 25th. The company reported $0.93 earnings per share for the quarter, topping the consensus estimate of $0.88 by $0.05. The business had revenue of $10.75 billion during the quarter, compared to analysts’ expectations of $16.86 billion. Sanofi had a net margin of 9.60% and a return on equity of 26.29%. Sanofi’s revenue was up 7.8% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.95 earnings per share. On average, research analysts anticipate that Sanofi will post 4.25 EPS for the current fiscal year.

Sanofi Profile

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products.